Emmanuel Vial

Emmanuel Vial Email and Phone Number

Pharmaceutical R&D Executive | Global Program Leader @ Granular Therapeutics Ltd
Emmanuel Vial's Location
Lausanne Metropolitan Area, Switzerland, Switzerland
About Emmanuel Vial

Senior pharmaceutical R&D executive with more than 15 years’ experience in international environments in various Program Leader and Head of Pharmacology roles, with strong track record in leading R&D projects from ideation to late-stage clinical developmentScience-driven and rigorous leader with strong business acumen providing strategic vision on projects thanks to a wide expertise acquired in multiple therapeutic areas with various drug modalities in small biotech as well as in large pharma companies- Companies: Galderma, Pharnext, Servier, Sanofi- Therapeutic areas: Dermatology, Inflammatory & Auto-Immune diseases, Oncology, Rare diseases- Drug modalities: Small molecules & Biologics, Systemic & Topical (skin) drug deliveryResults-oriented and motivating leader with strong people and team management skills, leading by example and finding the right balance between supervision and empowerment

Emmanuel Vial's Current Company Details
Granular Therapeutics Ltd

Granular Therapeutics Ltd

View
Pharmaceutical R&D Executive | Global Program Leader
Emmanuel Vial Work Experience Details
  • Granular Therapeutics Ltd
    Chief Development Officer (Cdo)
    Granular Therapeutics Ltd Jun 2023 - Present
  • Galderma
    Program Lead (Global R&D)
    Galderma Jan 2021 - May 2023
    Zug, Ch
    • Programs- Preclinical programs (Lead to IND submission)- Early and late-stage development programs (phase 1-3)• Main Missions- Lead cross functional teams of experts (Clinical, Regulatory, CMC, Medical Affairs, Marketing & Commercial)- Establish program strategy and long-term vision- Ensure program execution within timelines, budget and expected quality through alignment of global functions- Represent the programs internally and externally• Main achievements- Completed IND packages for 2 topical programs in Atopic Dermatitis- Led the design of a late stage asset global clinical development plan in a LCM indication (FDA-endorsed)- Successfully initiated a phase 3 study
  • Galderma
    Head Of Biology (Discovery, Dermatology)
    Galderma Sep 2018 - Dec 2020
    Zug, Ch
    • Missions - Led and managed global biology & pharmacology department and activities- Discovery Project Leader • Main activities in biology department- Biologics discovery (generation & engineering)- HTS, in vitro pharmacology & in vivo pharmacology (small molecules and biologics)- Externally focused (100% via collaborations & outsourcing to CROs)- Scientific assessment of external opportunities• Main achievements- Successfully led the transition of pharmacology and biology activities to a fully virtual R&D environment
  • Galderma
    Head Of Advanced Pharmacology (Discovery, Dermatology)
    Galderma Jul 2012 - Aug 2018
    Zug, Ch
    • Missions - Led the in vivo pharmacology department (20+ collaborators)- Discovery Project Leader• Main activities in the pharmacology department- Pharmacodynamy unit for target-based in vivo models and PK/PD- Immunology/Inflammation unit for disease-oriented in vivo models- Aesthetic & corrective unit for the evaluation of injectable fillers• Main achievements- Developed >30 in vivo efficacy and PK/PD models - Participated in the nomination of more than 10 clinical candidates
  • Pharnext
    Director Of Pharmacology (Discovery, Rare And Neurodegenerative Diseases)
    Pharnext Sep 2010 - Jun 2012
    Suresnes, Île-De-France, Fr
    • Lead the Pharmacology department (5 collaborators)• Discovery Project Leader (drug combination, Alzheimer disease)
  • Servier
    Head Of In Vivo Pharmacology (Discovery, Oncology)
    Servier Apr 2008 - Sep 2010
    Suresnes, Fr
    • Lead the in vivo pharmacology department (8 collaborators)• Discovery Project Leader (monoclonal antibody targeting the tumor metabolism)
  • Sanofi
    Study Director (Discovery, Oncology)
    Sanofi Jan 2007 - Dec 2007
    Paris, France, Fr
    • Lead an in vivo pharmacology team (3 collaborators)
  • Cnrs
    Post-Doc Ii
    Cnrs Sep 2003 - Dec 2006
    Paris, Fr
    Dr. Jacques Pouysségur’s laboratory • Study of cancer invasion in vivo • 2 publications as last author
  • Institute Of Cancer Research
    Post-Doc I
    Institute Of Cancer Research Oct 2000 - Jul 2003
    London, Greater London, Gb
    Pr. Chris Marshall’s laboratory • Role of Ras and Rho small GTPases in cancer progression • 2 publications as first author

Emmanuel Vial Education Details

  • École Normale Supérieure De Lyon
    École Normale Supérieure De Lyon
    Biology
  • École Normale Supérieure De Lyon
    École Normale Supérieure De Lyon
    Molecular And Cellular Biology
  • Université Grenoble Alpes
    Université Grenoble Alpes
    Chemistry

Frequently Asked Questions about Emmanuel Vial

What company does Emmanuel Vial work for?

Emmanuel Vial works for Granular Therapeutics Ltd

What is Emmanuel Vial's role at the current company?

Emmanuel Vial's current role is Pharmaceutical R&D Executive | Global Program Leader.

What schools did Emmanuel Vial attend?

Emmanuel Vial attended École Normale Supérieure De Lyon, École Normale Supérieure De Lyon, Université Grenoble Alpes.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.